D. E. Shaw & Co., Inc. - OYSTER PT PHARMA INC ownership

OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 2 filers reported holding OYSTER PT PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of OYSTER PT PHARMA INC
ValueSharesWeighting
Q3 2020$320,000
-74.3%
15,137
-64.8%
0.00%
-100.0%
Q2 2020$1,243,00043,0550.00%
Other shareholders
OYSTER PT PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 2,768,586$32,226,00014.34%
Paradigm Biocapital Advisors LP 987,698$11,497,0003.04%
NEA Management Company, LLC 5,925,287$68,970,0001.99%
KPCB XIV Associates, LLC 367,987$4,283,0001.61%
Telemark Asset Management, LLC 787,026$9,161,0000.81%
COWEN AND COMPANY, LLC 509,794$5,934,0000.57%
RTW INVESTMENTS, LP 2,058,504$23,961,0000.50%
ACT CAPITAL MANAGEMENT, LLC 13,500$157,0000.17%
Kohlberg Kravis Roberts & Co. L.P. 1,039,622$12,101,0000.11%
Wildcat Capital Management, LLC 36,847$429,0000.11%
View complete list of OYSTER PT PHARMA INC shareholders